Mortality rate for Irish heart attack patients has halved

The number of patients dying in hospital after presenting with a heart attack has almost halved over the past decade, the first audit of hospital mortality rates has shown.

The report from the National Office of Clinical Audit examined patients admitted with heart attacks, heart failure, stroke and chronic lung disease (chronic obstructive pulmonary disease and bronchiectasis) in 44 public acute hospitals between 2005 and 2015.

The report looked at the difference between the number of patients who died from a condition in a particular hospital and the number that would be expected to die on the basis of the overall national rate and the patient profile of the hospital.

The report said that the results cannot be used to compare hospitals as “no two are expected to be the same” in terms of the patients they deal with.

Nurses back industrial action over working conditions

---

Nursing case study: On front line of hospital ward crisis

---

Sugary-drink tax to have ‘benefits’ no matter industry response

---

Little in HSE service plan to spark enthusiasm for future

---

In terms of heart attacks, there was a “significant reduction” in deaths per 100 admissions, from 11.1 deaths in 2005 to 5.9 in 2015.

For heart failure, there was a “small but significant” reduction, from 9.6 deaths in 2005 to 7.9 in 2015.

For ischaemic stroke, there was a “small but significant” reduction, from 14.2 deaths in 2005 to 10.5 in 2015.

There was “almost no change” in the rates for haemorrhagic stroke and chronic lung disease.

All hospitals were within the expected range for heart attacks, heart failure, ischaemic and haemorrhagic stroke.

Mater Misericordiae

One hospital, the Mater Misericordiae in Dublin, was outside the range for chronic lung disease, meaning more patients died than would be expected.

The audit said the reasons for this could be due to differences in patient factors that were not fully accounted for in its model, differences in medical coding, or differences in the quality of care.

The hospital’s executive clinical director and its clinical director for quality and patient safety undertook a “thorough review” of both the coding and the clinical care for patients admitted with chronic lung disease.

The hospital's chief executive, Gordon Dunne, said the review had "not provided a definitive explanation . . . [but] neither has it raised any immediate concerns.

“It has, however, raised questions for further consideration,” he said.

“In exploring the data, we have concluded in general that the inclusion of palliative care-associated mortality has not significantly contributed to this change in mortality rate.

“The interpretation of coding of the primary admitting diagnosis from the clinical notes is challenging due to the complexity of presenting symptoms and existing co-morbidities,” he said.

Another issue arose in relation to the accuracy of reflecting the number and complexity of co-occurring diseases in patients and the significance of these in contributing to deaths.

He also said chronic lung disease “inherently leads to a bias in coding”, as it deflected from alternative diagnoses.

He said the situation would be “closely monitored” going forward.